Order results by:
Issue | Title | |
Vol 3, No 2 (2007) | OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina | ||
"... in patients suffering diabetes mellitus type 2, especially to the role of oxidative stress. It is determined ..." | ||
Vol 6, No 3 (2010) | EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS | Abstract similar documents |
S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva | ||
"... . Experimental diabetes mellitus was shown to be associated with the development of oxidative stress expressed ..." | ||
Vol 17, No 2 (2021) | Management of Patients with Chronic Heart Failure and Diabetes Mellitus | Abstract similar documents |
E. V. Reznik, T. L. Nguyen, G. N. Golukhov | ||
"... Chronic heart failure (CHF) occurs in 4.3-28% of patients with diabetes mellitus and is most often ..." | ||
Vol 11, No 3 (2015) | OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS | Abstract similar documents |
O. M. Drapkina, R. N. Shepel' | ||
"... . This therapeutic class slows down oxidative stress and chronic inflammation processes, thereby providing ..." | ||
Vol 9, No 4 (2013) | STATINS AND THE RISK OF DIABETES MELLITUS | Abstract similar documents |
O. M. Drapkina | ||
"... the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action ..." | ||
Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
"... on the salt sensitivity of hypertensive patients with diabetes mellitus type 2. Material and methods. 130 ..." | ||
Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
O. M. Drapkina, B. B. Gegenava | ||
"... The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis ..." | ||
Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
M. E. Statsenko, M. V. Derevyanchenko | ||
"... hypertension (HT) combined with type 2 diabetes mellitus (DM). Material and methods. 30 patients with stage ..." | ||
Vol 5, No 6 (2009) | INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS | Abstract similar documents |
A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv | ||
Vol 13, No 5 (2017) | NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE | Abstract similar documents |
O. M. Drapkina, A. A. Yafarova | ||
"... аdipocytokines profile. Such risk factors as arterial hypertension, dyslipidemia, obesity, diabetes mellitus type ..." | ||
Vol 12, No 6 (2016) | HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT | Abstract similar documents |
B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova | ||
"... of chronic heart failure (CHF) and diabetes mellitus (DM). The modern views on the epidemiology, pathogenesis ..." | ||
Vol 11, No 4 (2015) | DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM IN THE CARDIOLOGY PRACTICE: FOCUS ON THE ANALYSIS OF HEART RATE VARIABILITY | Abstract similar documents |
E. B. Akhmedova, B. U. Mardanov, M. N. Mamedov | ||
"... rhythm disorders, as well as diabetes mellitus (DM) is considered. A significant association between ..." | ||
Vol 11, No 5 (2015) | Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders | Abstract similar documents |
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov | ||
"... (STEMI) and the features of inpatient treatment in patients with and without diabetes mellitus (DM ..." | ||
Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
"... patients with diabetes mellitus (DM) in accordance with target blood pressure (BP) <130/80 mm Hg ..." | ||
Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract similar documents |
O. P. Shevchenko, А. О. Shevchenko | ||
"... . It contributes to inflammation of vessel intimae, oxidative stress, cells apoptosis, matrix remodeling, has pro ..." | ||
Vol 6, No 3 (2010) | ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY | Abstract similar documents |
V. A. Nevzorova, E. S. Potapova, O. V. Nastradin | ||
"... or metoprolol and its influence on markers of blood oxidative status in hypertensive patients with overweight ..." | ||
Vol 7, No 5 (2011) | CLINICAL EFFICACY OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETES MELLITUS AND ISCHEMIC HEART DISEASE | Abstract similar documents |
L. V. Kozlova, R. A. Khokhlov, N. M. Akhmedzhanov | ||
"... Aim. To study sulodexide clinical efficacy in patients with type 2 diabetes mellitus (DM ..." | ||
Vol 14, No 5 (2018) | Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population | Abstract similar documents |
O. M. Drapkina, R. N. Shepel, S. A. Shalnova, A. D. Deev, Yu. A. Balanova, S. E. Evstifeeva, Yu. V. Zhernakova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, O. P. Rotar, E. V. Shlyakhto, S. A. Boytsov | ||
"... Obesity is one of the main risk factors for type 2 diabetes developing. The question ..." | ||
Vol 16, No 4 (2020) | The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus | Abstract similar documents |
T. Yu. Demidova, O. A. Kislyak | ||
"... of type 2 diabetes mellitus and AH dramatically increases the risk of developing terminal stages ..." | ||
Vol 4, No 2 (2008) | ACUTE CORONARY SYNDROME IN PATIENTS WITH DIABETES MELLITUS: ON THE WAY TO MUNICH-2008 | Abstract similar documents |
I. I. Dedov, A. A. Alexanrov | ||
"... tolerance disturbances including 44% of patient with these reaching the level of diabetes mellitus (DM ..." | ||
Vol 3, No 5 (2007) | THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE | Abstract similar documents |
M. V. Ilyin, A. O. Khrustalev | ||
"... of neutrophil nitric oxide production was assessed. Chemiluminescent assay was used to evaluate oxidative ..." | ||
Vol 6, No 6 (2010) | REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" | Abstract similar documents |
A. A. Aleksandrov | ||
"... diabetes mellitus is studied insufficiently. Combined therapy with glibenclamide and metformin can result ..." | ||
Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
M. N. Kovrigina, M. N. Mamedov | ||
"... Aim. To assess the risk of diabetes mellitus type 2 (DM2) in patients with various cardiovascular ..." | ||
Vol 12, No 4 (2016) | Fighting with obesity: the "gold standard" and new horizons | Abstract similar documents |
O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov | ||
"... , such as cardiovascular disease and type 2 diabetes. Therapy aimed at addressing the risk factors of adverse outcomes ..." | ||
Vol 13, No 1 (2017) | QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov | ||
"... with HT (I group, n=20; 52.7±9.9 years old); patients with HT and diabetes mellitus (DM) type 2 (II group ..." | ||
Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
"... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..." | ||
Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
"... ) or diabetes mellitus (DM) type 2. Material and methods. Patients with HT (2-3 degree) associated with IHD ..." | ||
Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
"... patients initially and 6 months later. Results. Patients with newly diagnosed diabetes were more likely ..." | ||
Vol 10, No 3 (2014) | ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova | ||
"... hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 hypertensive patients with DM ..." | ||
Vol 10, No 3 (2014) | THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW | Abstract similar documents |
D. A. Napalkov | ||
"... , myopathy and rhabdomyolysis, the impact on the diabetes and cognitive dysfunction onset, renal function ..." | ||
Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
M. V. Leonova | ||
"... in hypertensive patients with diabetes mellitus and chronic heart failure are discussed. Special attention is paid ..." | ||
Vol 8, No 1 (2012) | PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE | Abstract similar documents |
M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova | ||
"... to prevention of type 2 diabetes mellitus (DM). Data of international clinical trials shows that early GMD ..." | ||
Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
M. M. Batiushin | ||
"... causes of CKD C5 are diabetes mellitus (DM, 46.9%), hypertension (28.8%) and to a lesser extent ..." | ||
Vol 16, No 6 (2020) | Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment | Abstract similar documents |
V. Yu. Kopylov | ||
"... into 2 subgroups: patients with stage I chronic heart failure (CHF) without type 2 diabetes mellitus (DM2 ..." | ||
Vol 4, No 2 (2008) | COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva | ||
"... ) and diabetes mellitus (DM) type 2 after myocardial infarction (MI). Material and methods. 60 patients (45-70 y ..." | ||
Vol 20, No 3 (2024) | Long-term prognosis of life in patients with cerebrovascular accident: the role of diabetes mellitus (according to the REGION-M registry outpatient follow-up phase) | Abstract similar documents |
V. P. Voronina, A. V. Zagrebelny, Yu. V. Lukina, S. N. Tolpygina, N. P. Kutishenko, M. I. Chernysheva, M. M. Lukyanov, N. A. Dmitrieva, O. V. Lerman, S. Yu. Martsevich, O. M. Drapkina | ||
"... (CVA), and to determine the role of diabetes mellitus (DM) as a possible negative prognostic factor ..." | ||
Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
"... Diabetes mellitus (DM) is one of the health and social problems of modern health care. The main ..." | ||
Vol 5, No 5 (2009) | ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS | Abstract similar documents |
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina | ||
"... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..." | ||
Vol 19, No 5 (2023) | Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes | Abstract similar documents |
A. M. Kochergina, O. L. Barbarash | ||
"... ) profile in patients with hypertension (HTN), type 2 diabetes (T2D) and stable coronary artery disease (CAD ..." | ||
Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
"... Comorbid patients with atrial fibrillation, diabetes mellitus and chronic kidney disease ..." | ||
Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
T. Yu. Demidova, O. A. Kislyak | ||
"... The current understanding of the management of patients with diabetes mellitus (DM) based ..." | ||
Vol 15, No 3 (2019) | Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus | Abstract similar documents |
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis | ||
"... of type 2 diabetes mellitus. Material and methods. The study included patients with essential hypertension ..." | ||
Vol 3, No 5 (2007) | LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE | Abstract similar documents |
N. P. Kutishenko, S. J. Martsevich | ||
"... complicated with left ventricle dysfunction and diabetes (GISSI-3, ATLAS, ALLHAT, EUCLID) are presented ..." | ||
Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
"... Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type ..." | ||
Vol 11, No 2 (2015) | DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES | Abstract similar documents |
A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko | ||
"... in many studies, but the dynamics of its levels in patients with concomitant diabetes mellitus (DM) type 2 ..." | ||
Vol 12, No 6 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract PDF (Eng) similar documents |
M. E. Statsenko, M. V. Derevyanchenko | ||
"... ) in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 ..." | ||
Vol 12, No 1 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract similar documents |
M. E. Statsenko, M. V. Derevyanchenko | ||
"... ) in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 ..." | ||
Vol 15, No 1 (2019) | How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? | Abstract similar documents |
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov | ||
"... The number of elderly patients with diabetes mellitus (DM) is constantly growing in general ..." | ||
Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
Vol 18, No 3 (2022) | The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus | Abstract PDF (Eng) similar documents |
O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov | ||
"... in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (DM). Material and methods ..." | ||
Vol 17, No 3 (2021) | New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract PDF (Eng) similar documents |
A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov | ||
"... , CKD and diabetes mellitus. Material and methods. 60 patients with atrial fibrillation (AF) and CKD ..." | ||
Vol 12, No 2 (2016) | THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES | Abstract similar documents |
M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov | ||
"... diabetes at high cardiovascular risk. ..." | ||
Vol 15, No 6 (2019) | Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus | Abstract similar documents |
A. V. Zhito, A. O. Iusupova, E. V. Privalova, N. V. Khabarova, Yu. N. Belenkov | ||
"... The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes ..." | ||
Vol 15, No 3 (2019) | Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders | Abstract similar documents |
L. D. Khidirova, D. A. Yakhontov, S. A. Zenin, M. N. Mamedov | ||
"... comorbid extracardiac diseases: diabetes mellitus (DM; n=40), diffuse toxic goiter (DTG; n=42 ..." | ||
Vol 20, No 4 (2024) | The oxytocin-oxytocin receptors system — a new pathogenetic mechanism in the development of diabetic phenotype of heart failure with preserved ejection fraction in women | Abstract similar documents |
A. D. Starchenko, Yu. V. Liskova, A. A. Stadnikov | ||
"... (HFpEF) associated with type 2 diabetes mellitus (DM2T) (diabetic phenotype of HFpEF). Material ..." | ||
Vol 9, No 3 (2013) | EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA) | Abstract similar documents |
, , , , , , , , , , , | ||
Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
"... outcomes in patients with atherosclerosis and diabetes mellitus type 2 (DM2). Material and methods. 154 ..." | ||
Vol 14, No 5 (2018) | Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting | Abstract similar documents |
A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash | ||
"... Aim. To assess the relationship between pre-diabetes/type 2 diabetes mellitus (type 2 DM ..." | ||
Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
O. A. Koshel'skaya, O. A. Zhuravleva | ||
"... 2 diabetes mellitus (DM) who achieved the target BP levels (<130/80 mmHg) due to long-term combined ..." | ||
Vol 20, No 1 (2024) | Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome | Abstract similar documents |
E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, N. A. Rakhimi, A. A. Bogdanova, A. V. Ploshchenkov | ||
"... .8% of cases. Patients with no-/slow-reflow phenomenon more frequently had diabetes mellitus (42.4% vs. 22 ..." | ||
Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
"... ингибиторов ангиотензинпревращающего фермента (АПФ) при остром инфаркте миокарда. Обсуждаются причины ..." | ||
Vol 3, No 4 (2007) | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
I. V. Szirov, E. V. Malichenko | ||
"... Ингибиторы ангиотензинпревращающего фермента являются препаратами первой линии в терапии ..." | ||
Vol 5, No 3 (2009) | COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) | Abstract similar documents |
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova | ||
"... ) and diabetes mellitus 2 type (DM2) and/or obesity. Material and methods. 592 patients: 176 men (29,7%) and 416 ..." | ||
Vol 13, No 6 (2017) | FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES | Abstract similar documents |
D. А. Napalkov, A. A. Sokolova | ||
"... of myocardial infarction, diabetes mellitus, and chronic kidney disease are presented. The principles ..." | ||
Vol 20, No 2 (2024) | Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect | Abstract similar documents |
O N. Kurochkina, D. A. Korotkov, A. S. Sazhina, A N. Bogomolov | ||
"... ), drugs for type 2 diabetes mellitus treatment, significantly improve metabolic parameters and have ..." | ||
Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
D. A. Napalkov, E. N. Golovenko | ||
Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
S. N. Tereshchenko, N. A. Dzhaiani | ||
Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
D. B. Nebieridze, A. S. Safaryan | ||
"... ингибиторов ангиотензинпревращающего фермента (АПФ) в клинической практике. Традиционное применение ..." | ||
Vol 14, No 5 (2018) | Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case | Abstract similar documents |
M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov | ||
"... with type 2 diabetes mellitus and liver fibrosis demonstrates a combination of polyvalent risk factors ..." | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... older (75 vs 72 years, p=0.001), more often had type 2 diabetes mellitus (T2DM) (28.6% vs 20.5%, p=0 ..." | ||
Vol 11, No 1 (2015) | METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
M. E. Statsenko, M. V. Derevyanchenko | ||
"... hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 patients with HT stage II-III ..." | ||
Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
"... ’s”, India) on morphofunctional heart indices, intensity of systemic inflammation and oxidative stress ..." | ||
Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
"... Ингибиторы ангиотензинпревращающего фермента (иАПФ) и антагонисты рецепторов к ангиотензину (АРА ..." | ||
Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
S. Yu. Martsevich | ||
"... Описываются основные исследования, доказавшие влияние ингибиторов ангиотензинпревращающего ..." | ||
Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
S. Yu. Martsevich | ||
Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
S. Yu. Martsevich | ||
"... ингибиторов ангиотензинпревращающего фермента (иАПФ) и антагонистов рецепторов ангиотензина II (АРА) у больных ..." | ||
Vol 9, No 2 (2013) | A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE | Abstract similar documents |
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi | ||
"... .10.011 Цель. Оценить влияние ингибиторов ангиотензинпревращающего фермента (ИАПФ) и блокаторов рецепторов ..." | ||
Vol 17, No 3 (2021) | Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies) | Abstract PDF (Eng) similar documents |
G. V. Artamonova, S. A. Maksimov, D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, T. A. Mulerova, E. B. Shapovalova, A. S. Agienko, O. V. Nakhratova, O. L. Barbarash | ||
"... analyzed the prevalence of smoking, diabetes mellitus, overweight and obesity, abdominal obesity ..." | ||
Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
"... " (CSS), arterial hypertension, chronic heart failure, diabetes mellitus. The need for a combination ..." | ||
Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
"... ) and diuretic. Material and methods. Patients with arterial hypertension degree 2 and diabetes mellitus type 2 ..." | ||
Vol 3, No 2 (2007) | CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) | Abstract similar documents |
V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin | ||
"... and diabetes mellitus. Results. CR was found in 18 of 447 patients (4%) of group I (1989), in 16 of 475 ..." | ||
Vol 12, No 1 (2016) | The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev | ||
"... =1.1). The probability of death increased in the presence of diabetes mellitus (RR=1.4), alcohol ..." | ||
Vol 8, No 3 (2012) | EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE | Abstract similar documents |
T. N. Khaybullin, E. Yu. Kravtsova, G. A. Martynova | ||
"... Aim. To study the effect of ethylmethylhydroxypyridine succinate (EMHPS) on the protein oxidative ..." | ||
Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
K. A. Gyamdzhyan, M. L. Maksimov | ||
Vol 5, No 6 (2009) | ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE | Abstract similar documents |
E. A. Ryabikhin, M. E. Mozheiko | ||
Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
O. D. Ostroumova, I. I. Kopchenov | ||
"... ангиотензинпревращающего фермента (АПФ) с дигидропиридиновым антагонистом кальция. Приведены данные литературы об ..." | ||
Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
S. Yu. Martsevich | ||
Vol 1, No 1 (2005) | EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE | Abstract similar documents |
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen | ||
Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
"... ингибитора ангиотензинпревращающего фермента (иАПФ) эналаприла (Энам, Dr.Reddy’s). Материал и методы ..." | ||
Vol 14, No 6 (2018) | Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich | ||
"... ангиотензинпревращающего фермента способствуют развитию рака легких. Отмечается, что анализ потенциального риска от приема ..." | ||
Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
"... Цель работы. Оценить влияние ингибитора ангиотензинпревращающего фермента (АПФ) эналаприла на ..." | ||
Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
O. V. Andropova, V. N. Anokhin | ||
Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
N. A. Dzhaiani | ||
"... и ингибитора ангиотензинпревращающего фермента эналаприла. ..." | ||
Vol 17, No 1 (2021) | Cardiomyopathy of Friedreich's Disease. Modern Methods of Diagnostic | Abstract PDF (Eng) similar documents |
E. I. Fomicheva, R. P. Myasnikov, Y. A. Selivyorstov, S. N. Illarioshkin, E. L. Dadali, O. M. Drapkina | ||
"... , pyramid signs, diabetes mellitus, visual impairment. Friedreich's ataxia is the most common of all ..." | ||
Vol 3, No 4 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
"... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
Vol 3, No 4 (2007) | COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
An. A. Alexandrov | ||
"... Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. ..." | ||
Vol 3, No 5 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
"... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
Vol 6, No 2 (2010) | NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER | Abstract similar documents |
T. Műnzel, T. Gori | ||
Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
"... . Ингибиторы ангиотензинпревращающего фермента (АПФ) по-прежнему занимают важное место в лечении артериальной ..." | ||
Vol 9, No 2 (2013) | ROLE OF INSULIN RESISTANCE AND ITS CORRECTION IN THE PROCESS OF VASCULAR AGING | Abstract similar documents |
E. N. Dudinskaya, O. N. Tkacheva, I. D. Strazhesko, D. U. Akasheva | ||
"... Insulin resistance plays the main role in the pathogenesis of diabetes mellitus and its ..." | ||
1 - 100 of 274 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)